COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform

Yazed AlRuthia; Sulaiman A. Alrashed; Bander Balkhi; Mohammed S. Aljamal; Saud Alsifri; Ali M. Alrumaih; Fahad Alsabaan; Mai Alsaqa'aby; Hana A. Al-Abdulkarim; Abdulaziz I. Altowaijri

doi:10.1016/j.hlpt.2020.10.008

Back

COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform

Journal article

Open access

Peer reviewed

COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform

Yazed AlRuthia, Sulaiman A. Alrashed, Bander Balkhi, Mohammed S. Aljamal, Saud Alsifri, Ali M. Alrumaih, Fahad Alsabaan, Mai Alsaqa'aby, Hana A. Al-Abdulkarim and Abdulaziz I. Altowaijri

Health policy and technology, Vol.10(1), pp.3-6

03/2021

DOI: https://doi.org/10.1016/j.hlpt.2020.10.008

Abstract

COVID-19

Economics

Health Policy

Pharmaceutical

Saudi Arabia

Files and links (1)

url

https://doi.org/10.1016/j.hlpt.2020.10.008View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform
Creators - without role: Yazed AlRuthia - King Saud University
Sulaiman A. Alrashed - Riyadh Armed Forces Hospital
Bander Balkhi - King Saud University
Mohammed S. Aljamal - Armed Forces Hospital
Saud Alsifri - Armed Forces Hospital
Ali M. Alrumaih - Riyadh Armed Forces Hospital
Fahad Alsabaan - Security Forces Hospital
Mai Alsaqa'aby - IQVIA
Hana A. Al-Abdulkarim - National Guard Health Affairs
Abdulaziz I. Altowaijri - Prince Sultan University
Publication Details: Health policy and technology, Vol.10(1), pp.3-6
Publisher: Elsevier Ltd
Identifiers: 9947154908331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article